Search research articles
Contact Us
Filters
Showing results (11-20 of 50) with videos related to
Page
of 5
Sort By:
Proceedings of the National Academy of Sciences of the United States of America
|
July 5, 2008
Programmed death 1 ligand signaling regulates the generation of adaptive Foxp3+CD4+ regulatory T cells
Li Wang, Karina Pino-Lagos, Victor C de Vries, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
October 4, 2007
A link between PDL1 and T regulatory cells in fetomaternal tolerance
Antje Habicht, Shirine Dada, Mollie Jurewicz, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
March 7, 2006
Differential role of programmed death-ligand 1 [corrected] and programmed death-ligand 2 [corrected] in regulating the susceptibility and chronic progression of experimental autoimmune encephalomyelitis
Bing Zhu, Indira Guleria, Arezou Khosroshahi, et al.
The American Journal of Pathology
|
April 22, 2017
Divergent Function of Programmed Death-Ligand 1 in Donor Tissue versus Recipient Immune System in a Murine Model of Bronchiolitis Obliterans
Katharina Schütte-Nütgen, Olaf Boenisch, Hakima Harrach, et al.
Clinical Immunology (Orlando, Fla.)
|
September 25, 2007
Role of ICOS pathway in autoimmune and alloimmune responses in NOD mice
Mohammed Javeed I Ansari, Paolo Fiorina, Shirine Dada, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
September 28, 2011
The link between the PDL1 costimulatory pathway and Th17 in fetomaternal tolerance
Francesca D'Addio, Leonardo V Riella, Bechara G Mfarrej, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
November 28, 2012
TIM-3 regulates innate immune cells to induce fetomaternal tolerance
Lola Chabtini, Bechara Mfarrej, Marwan Mounayar, et al.
The Journal of Experimental Medicine
|
November 23, 2006
Insulin-induced remission in new-onset NOD mice is maintained by the PD-1-PD-L1 pathway
Brian T Fife, Indira Guleria, Melanie Gubbels Bupp, et al.
Nature Communications
|
March 21, 2023
Clonal dynamics of alloreactive T cells in kidney allograft rejection after anti-PD-1 therapy
Garrett S Dunlap, Daniel DiToro, Joel Henderson, et al.
Cancer Immunology, Immunotherapy : CII
|
July 19, 2019
Immunity to X-linked inhibitor of apoptosis protein (XIAP) in malignant melanoma and check-point blockade
Jun Zhou, Jingjing Li, Indira Guleria, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 50) with videos related to
Sort By:
Page
of 5
Proceedings of the National Academy of Sciences of the United States of America
|
July 5, 2008
Programmed death 1 ligand signaling regulates the generation of adaptive Foxp3+CD4+ regulatory T cells
Li Wang, Karina Pino-Lagos, Victor C de Vries, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
October 4, 2007
A link between PDL1 and T regulatory cells in fetomaternal tolerance
Antje Habicht, Shirine Dada, Mollie Jurewicz, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
March 7, 2006
Differential role of programmed death-ligand 1 [corrected] and programmed death-ligand 2 [corrected] in regulating the susceptibility and chronic progression of experimental autoimmune encephalomyelitis
Bing Zhu, Indira Guleria, Arezou Khosroshahi, et al.
The American Journal of Pathology
|
April 22, 2017
Divergent Function of Programmed Death-Ligand 1 in Donor Tissue versus Recipient Immune System in a Murine Model of Bronchiolitis Obliterans
Katharina Schütte-Nütgen, Olaf Boenisch, Hakima Harrach, et al.
Clinical Immunology (Orlando, Fla.)
|
September 25, 2007
Role of ICOS pathway in autoimmune and alloimmune responses in NOD mice
Mohammed Javeed I Ansari, Paolo Fiorina, Shirine Dada, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
September 28, 2011
The link between the PDL1 costimulatory pathway and Th17 in fetomaternal tolerance
Francesca D'Addio, Leonardo V Riella, Bechara G Mfarrej, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
November 28, 2012
TIM-3 regulates innate immune cells to induce fetomaternal tolerance
Lola Chabtini, Bechara Mfarrej, Marwan Mounayar, et al.
The Journal of Experimental Medicine
|
November 23, 2006
Insulin-induced remission in new-onset NOD mice is maintained by the PD-1-PD-L1 pathway
Brian T Fife, Indira Guleria, Melanie Gubbels Bupp, et al.
Nature Communications
|
March 21, 2023
Clonal dynamics of alloreactive T cells in kidney allograft rejection after anti-PD-1 therapy
Garrett S Dunlap, Daniel DiToro, Joel Henderson, et al.
Cancer Immunology, Immunotherapy : CII
|
July 19, 2019
Immunity to X-linked inhibitor of apoptosis protein (XIAP) in malignant melanoma and check-point blockade
Jun Zhou, Jingjing Li, Indira Guleria, et al.
Page
of 5